Current concepts of pain management for cancer patients

Oncology Reviews

Volumn 2, Issue 3, 2008, Pages 154-163

  Feng, Yin Hsun ^c   Wang, Ying Wai ^b   Yeung, Sai Ching Jim ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Cancer pain; Opiate; Side effect; WHO analgesic ladder

Indexed keywords

EID: 70350435937     PISSN: 19705557     EISSN: 19705565     Source Type: Journal    
DOI: 10.1007/s12156-008-0071-3     Document Type: Review

References (69)

1. Zeppetella G, Ribeiro MD (2003) Pharmacotherapy of cancerrelated episodic pain. Expert Opin Pharmacother 4:493-502
2. World Health Organization (1987) Alivio del dolor en el cancer. World Health Organization, Geneva Switzerland
3. McDonnell FJ, Sloan JW, Hamann SR (2001) Advances in cancer pain management. Curr Pain Headache Rep 5:265-271
4. Seymour J, Clark D, Winslow M (2005) Pain and palliative care: the emergence of new specialities. J Pain Symptom Manage 29:2-13 (Pubitemid 40126220)
5. Meldrum M (2005) The ladder and the clock: cancer pain and public policy at the end of the twentieth century. J Pain Symptom Manage 29:41-54 (Pubitemid 40126224)
6. Walsh D (2005) Advances in opioid therapy and formulations. Support Care Cancer 13:138-144 (Pubitemid 40468959)
7. Grond S, Radbruch L, Meuser T et al (1999) Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain 79:15-20 (Pubitemid 29012430)
8. Maltoni M, Scarpi E, Modonesi C et al (2005) Avalidation study of the WHO analgesic ladder: a two-step vs three-step strategy. Support Care Cancer 13:888-894 (Pubitemid 41502248)
9. Marinangeli F, Ciccozzi A, Leonardis M et al (2004) Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manage 27:409-416 (Pubitemid 38569646)
10. Dean M (2004) Opioids in renal failure and dialysis patients. J Pain Symptom Manage 28:497-504 (Pubitemid 39422488)
11. Mystakidou K, Katsouda E, Parpa E et al (2005) Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics. Am J Hosp Palliat Care 22:228-232 (Pubitemid 40745022)
12. Burton AW, Driver LC, Mendoza TR, Syed G (2004) Oral transmucosal fentanyl citrate in the outpatient management of severe cancer pain crises: a retrospective case series. Clin J Pain 20:195-197 (Pubitemid 38544040)
13. Gourlay GK (2001) Treatment of cancer pain with transdermal fentanyl. Lancet Oncol 2:165-172 (Pubitemid 33585928)
14. Menahem S, Shvartzman P (2004) High-dose fentanyl patch for cancer pain. J Am Board Fam Pract 17:388-390
15. Meadows M (2006) In: Proper use of fentanyl pain patches. Food and Drug Administration Consumer Magazine March-April. Available via DIALOG. http://www.fda.gov/fdac/features/2006/206-fentanyl.html. Accessed 20 May 2008
16. Evans R (2003) The effectiveness of transdermal fentanyl in palliative care. Nurs Times 99:24-25
17. Kornick CA, Santiago-Palma J, Moryl N et al (2003) Benefitrisk assessment of transdermal fentanyl for the treatment of chronic pain. Drug Saf 26:951-973 (Pubitemid 37330557)
18. Soares LG, Martins M, Uchoa R (2003) Intravenous fentanyl for cancer pain: a "fast titration" protocol for the emergency room. J Pain Symptom Manage 26:876-881 (Pubitemid 37101235)
19. Mercadante S, Villari P, Ferrera P, Casuccio A (2004) Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Support Care Cancer 12:762-766 (Pubitemid 40064258)
20. Davis MP, LeGrand SB, Lagman R (2005) Look before leaping: combined opioids may not be the rave. Support Care Cancer 13:769-774 (Pubitemid 41414016)
21. Zeppetella G, Paul J, Ribeiro MD (2003) Analgesic efficacy of morphine applied to painful ulcers. J Pain Symptom Manage 25:555-558 (Pubitemid 36629279)
22. Pol O, Alameda F, Puig MM (2001) Inflammation enhances muopioid receptor transcription and expression in mice intestine. Mol Pharmacol 60:894-899 (Pubitemid 33027423)
23. Cerchietti L (2007) Morphine mouthwashes for painful mucositis. Support Care Cancer 15:115-116; author reply 117
24. Zeppetella G, Ribeiro MD (2005) Morphine in intrasite gel applied topically to painful ulcers. J Pain Symptom Manage 29:118-119 (Pubitemid 40279048)
25. Long TD, Cathers TA, Twillman R et al (2001) Morphine-Infused silver sulfadiazine (MISS) cream for burn analgesia: a pilot study. J Burn Care Rehabil 22:118-123 (Pubitemid 32285122)
26. Cerchietti L (2007) Morphine mouthwashes for painful mucositis. Support Care Cancer 15:115-116; author reply 117
27. Cerchietti LC, Navigante AH, Korte MW et al (2003) Potential utility of the peripheral analgesic properties of morphine in stomatitis-related pain: a pilot study. Pain 105:265-273 (Pubitemid 37162496)
28. Cerchietti LC, Navigante AH, Bonomi MR et al (2002) Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer 95:2230-2236 (Pubitemid 35253386)
29. Gairard-Dory AC, Schaller C, Mennecier B et al (2005) Chemoradiotherapy-induced esophagitis pain relieved by topical morphine: three cases. J Pain Symptom Manage 30:107-109 (Pubitemid 41206573)
30. Kolesnikov YA, Pasternak GW (1999) Peripheral blockade of topical morphine tolerance by ketamine. Eur J Pharmacol 374:R1-R2 (Pubitemid 29287148)
31. Kolesnikov YA, Chereshnev I, Pasternak GW (2000) Analgesic synergy between topical lidocaine and topical opioids. J Pharmacol Exp Ther 295:546-551
32. Gallagher RE, Arndt DR, Hunt KL (2005) Analgesic effects of topical methadone: a report of four cases. Clin J Pain 21:190-192 (Pubitemid 40280235)
33. Krajnik M, Zylicz Z (1997) Topical morphine for cutaneous cancer pain. Palliat Med 11:325 (Pubitemid 27373038)
34. Watterson G, Howard R, Goldman A (2004) Peripheral opioids in inflammatory pain. Arch Dis Child 89:679-681
35. Bell RF, Eccleston C, Kalso E (2003) Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review. J Pain Symptom Manage 26:867-875
36. Bell R, Eccleston C, Kalso E (2003) Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev:CD003351
37. Mercadante S, Arcuri E, Tirelli W, Casuccio A (2000) Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manage 20:246-252
38. Lossignol DA, Obios-Portis M, Body J (2005) Successful use of ketamine for intractable cancer pain. Support Care Cancer 13:188-193 (Pubitemid 40468966)
39. Kannan TR, Saxena A, Bhatnagar S, Barry A (2002) Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients. J Pain Symptom Manage 23:60-65 (Pubitemid 34093884)
40. Fitzgibbon EJ, Hall P, Schroder C, Seely J et al (2002) Low dose ketamine as an analgesic adjuvant in difficult pain syndromes: a strategy for conversion from parenteral to oral ketamine. J Pain Symptom Manage 23:165-170 (Pubitemid 34158651)
41. Kotlinska-Lemieszek A, Luczak J (2004) Subanesthetic ketamine: an essential adjuvant for intractable cancer pain. J Pain Symptom Manage 28:100-102 (Pubitemid 38970071)
42. Fitzgibbon EJ, Viola R (2005) Parenteral ketamine as an analgesic adjuvant for severe pain: development and retrospective audit of a protocol for a palliative care unit. J Palliat Med 8:49-57 (Pubitemid 40144251)
43. Bryson J, Tamber A, Seccareccia D, Zimmermann C (2006) Methadone for treatment of cancer pain. Curr Oncol Rep 8:282-288 (Pubitemid 43970979)
44. Mannino R, Coyne P, Swainey C et al (2006) Methadone for cancer-related neuropathic pain: a review of the literature. J Opioid Manag 2:269-276
45. Bryson J, Tamber A, Seccareccia D, Zimmermann C (2006) Methadone for treatment of cancer pain. Curr Oncol Rep 8:282-288 (Pubitemid 43970979)
46. Benítez-Rosario MA, Feria M, Salinas-Martínez-Castollo LP, Martín-Ortega JJ (2004) Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain. Cancer 101:2866-2873
47. Lussier D, Huskey AG, Portenoy RK (2004) Adjuvant analgesics in cancer pain management. Oncologist 9:571-591 (Pubitemid 39332322)
48. Clifford DB (1985) Treatment of pain with antidepressants. Am Fam Physician 31:181-185 (Pubitemid 15137956)
49. Katherine E, Galluzzi DO (2007) Managing neuropathic pain. J Am Osteopath Assoc 107:ES39-ES48
50. Kalso E, Tasmuth T, Neuvonen PJ (1996) Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain 64:293-302 (Pubitemid 26130869)
51. Tasmuth T, Härtel B, Kalso E (2002) Venlafaxine in neuropathic pain following treatment of breast cancer. Eur J Pain 6:17-24
52. Wiffen PJ, McQuay HJ, Moore RA (2005) Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev:CD005451
53. Backonja MM (2000) Anticonvulsants (antineuropathics) for neuropathic pain syndromes. Clin J Pain 16:S67-S72
54. Luo ZD, Calcutt NA, Higuera ES (2002) Injury type-specific calcium channel a2d subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effect of gabapentin. J Pharmcol Exp Ther 303:1199-1205 (Pubitemid 35424406)
55. Caraceni A, Zecca E, Bonezzi C et al (2004) Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 22:2909-2917 (Pubitemid 41079911)
56. Wiffen PJ, McQuay HJ, Edwards JE, Moore RA (2005) Gabapentin for acute and chronic pain. Cochrane Database Syst Rev:CD005452
57. Siddall PJ, Cousins MJ, Otte A et al (2006) Pregabalin in central neuropathic pain associated with spinal cord injury: a placebocontrolled trial. Neurology 67:1792-1800 (Pubitemid 44900755)
58. Enggaard TP, Klitgaard NA, Sindrup SH (2006) Specific effect of levetiracetam in experimental human pain models. Eur J Pain 10:193-198 (Pubitemid 43255205)
59. Moulin DE, Clark AJ, Gilron I et al (2007) Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 12:13-21 (Pubitemid 46744774)
60. Davis MP (2007) What is new in neuropathic pain? Support Care Cancer 15:363-372 (Pubitemid 46697011)
61. Durnin C, Hind ID, Ghani SP et al (2001) Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in subjects with moderate hepatic impairment. Proc West Pharmacol Soc 44:83-84 (Pubitemid 34087722)
62. Izzedine H, Launay-Vacher V, Abbara C et al (2002) Pharmacokinetics of tramadol in a hemodialysis patient. Nephron 92:755-756
63. Launay-Vacher V, Karie S, Fau JB et al (2005) Treatment of pain in patients with renal insufficiency: the World Health Organization three-step ladder adapted. J Pain 6:137-148 (Pubitemid 40365017)
64. Nagaoka E, Minami K, Shiga Y et al (2002) Tramadol has no effect on cortical renal blood flow - despite increased serum catecholamine levels - in anesthetized rats: implications for analgesia in renal insufficiency. Anesth Analg 94:619-625 (Pubitemid 34177560)
65. McClain DA, Hug CC (1980) Intravenous fentanyl kinetics. Clin Pharmacol Ther 28:106-114 (Pubitemid 10090693)
66. D'Honneur G, Gilton A, Sandouk P et al (1994) Plasma and cerebrospinal fluid concentrations of morphine and morphine glucuronides after oral morphine. The influence of renal failure. Anesthesiology 81:87-93 (Pubitemid 24223668)
67. Lugo RA, Satterfield KL, Kern SE (2005) Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother 19:13-24
68. Filitz J, Griessinger N, Sittl R et al (2006) Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine. Eur J Pain 10:743-748 (Pubitemid 44430173)
69. Boger RH (2006) Renal impairment: a challenge for opioid treatment? The role of buprenorphine. Palliat Med 20 [Suppl 1]:s17-s23 (Pubitemid 43871330)